Phase I study of sorafenib in patients with refractory or relapsed acute leukemias.
Borthakur G, Kantarjian H, Ravandi F, Zhang W, Konopleva M, Wright JJ, Faderl S, Verstovsek S, Mathews S, Andreeff M, Cortes JE.
Borthakur G, et al.
Haematologica. 2011 Jan;96(1):62-8. doi: 10.3324/haematol.2010.030452. Epub 2010 Oct 15.
Haematologica. 2011.
PMID: 20952518
Free PMC article.
Clinical Trial.